Literature DB >> 1192687

Paradoxical diuresis after vasopressin administration to patients with neurohypophyseal diabetes insipidus treated with chlorpropamide, carbamazepine or clofibrate.

A E Meinders, A M van Leeuwen, J G Borst, V Cejka.   

Abstract

1. Chlorpropamide, carbamazepine and clofibrate have an antidiuretic action in patients with neurohypophyseal diabetes insipidus which is qualitatively similar to that of antidiuretic hormone (ADH). 2. An additive antidiuretic effect is produced by combination of chlorpropamide and carbamazepine with small dosages of ADH. 3. After an immediate and transient antidiuresis, a single intravenous bolus injection of lysine vasopressin given during treatment with chlorpropamide, chlorpropamide with a continuous intravenous infusion of lysine vasopressin, carbamazepine or clofibrate, resulted in increased water diuresis for 12-24 h or longer. 4. This paradoxical diuresis was not observed during treatment with chlorothiazide. 5. It is suggested that the antidiuretic action of chlorpropamide, carbamazepine and clofibrate is localized at the receptor site for ADH in the distal renal tubular cell.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1192687     DOI: 10.1042/cs0490283

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  6 in total

1.  Response of antidiuretic hormone to chlorpropamide.

Authors:  R Huupponen; R Lammintausta; O Viinamäki; J Viikari
Journal:  Br Med J       Date:  1980-11-15

2.  Transepithelial water movement in response to carbamazepine, chlorpropamide and demeclocycline in toad urinary bladder.

Authors:  M R Hirji; J C Mucklow
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus.

Authors:  E Kusano; J L Braun-Werness; D J Vick; M J Keller; T P Dousa
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

4.  Oxcarbazepine Therapy for Complete Central Diabetes Insipidus.

Authors:  Basmah Abdallah; Spencer Hodgins; Daniel Landry; Michael O'shea; Gregory Braden
Journal:  Case Rep Nephrol Dial       Date:  2018-01-31

Review 5.  Pathophysiology of Drug-Induced Hyponatremia.

Authors:  Gheun-Ho Kim
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

Review 6.  The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia.

Authors:  Sua Kim; Chor Ho Jo; Gheun-Ho Kim
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.